Structure

Physi-Chem Properties

Molecular Weight:  316.09
Volume:  311.205
LogP:  2.539
LogD:  2.775
LogS:  -3.811
# Rotatable Bonds:  3
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.803
Synthetic Accessibility Score:  3.01
Fsp3:  0.235
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.824
MDCK Permeability:  9.864299499895424e-06
Pgp-inhibitor:  0.006
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.012
20% Bioavailability (F20%):  0.807
30% Bioavailability (F30%):  0.92

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.037
Plasma Protein Binding (PPB):  97.96324920654297%
Volume Distribution (VD):  0.475
Pgp-substrate:  2.429558515548706%

ADMET: Metabolism

CYP1A2-inhibitor:  0.973
CYP1A2-substrate:  0.87
CYP2C19-inhibitor:  0.718
CYP2C19-substrate:  0.065
CYP2C9-inhibitor:  0.773
CYP2C9-substrate:  0.911
CYP2D6-inhibitor:  0.809
CYP2D6-substrate:  0.897
CYP3A4-inhibitor:  0.835
CYP3A4-substrate:  0.253

ADMET: Excretion

Clearance (CL):  14.806
Half-life (T1/2):  0.757

ADMET: Toxicity

hERG Blockers:  0.075
Human Hepatotoxicity (H-HT):  0.124
Drug-inuced Liver Injury (DILI):  0.643
AMES Toxicity:  0.457
Rat Oral Acute Toxicity:  0.16
Maximum Recommended Daily Dose:  0.501
Skin Sensitization:  0.916
Carcinogencity:  0.548
Eye Corrosion:  0.003
Eye Irritation:  0.906
Respiratory Toxicity:  0.191

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472912

Natural Product ID:  NPC472912
Common Name*:   5,7-Dihydroxy-3-(3'-Hydroxy-4'-Methoxybenzyl)-4-Chromanone
IUPAC Name:   (3R)-5,7-dihydroxy-3-[(3-hydroxy-4-methoxyphenyl)methyl]-2,3-dihydrochromen-4-one
Synonyms:  
Standard InCHIKey:  WIBOONWRYQFYQJ-SNVBAGLBSA-N
Standard InCHI:  InChI=1S/C17H16O6/c1-22-14-3-2-9(5-12(14)19)4-10-8-23-15-7-11(18)6-13(20)16(15)17(10)21/h2-3,5-7,10,18-20H,4,8H2,1H3/t10-/m1/s1
SMILES:  COc1ccc(cc1O)C[C@@H]1COc2c(C1=O)c(O)cc(c2)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3594087
PubChem CID:   638295
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002507] Homoisoflavonoids
        • [CHEMONTID:0002508] Homoisoflavans
          • [CHEMONTID:0002898] Homoisoflavanones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33045 bellevalia eigii Species Hyacinthaceae Eukaryota Bulbs Irbid, Jordan n.a. PMID[26147490]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell Line HT-29 Homo sapiens ED50 = 1.33 uM PMID[510187]
NPT400 Cell Line MDA-MB-435 Homo sapiens ED50 = 2.78 uM PMID[510187]
NPT139 Cell Line HT-29 Homo sapiens IC50 > 20000.0 nM PMID[510187]
NPT400 Cell Line MDA-MB-435 Homo sapiens IC50 = 1000.0 nM PMID[510187]
NPT20 Organism Candida albicans Candida albicans MIC > 138.0 ug.mL-1 PMID[510187]
NPT602 Organism Mycobacterium smegmatis Mycobacterium smegmatis MIC = 17.0 ug.mL-1 PMID[510187]
NPT19 Organism Escherichia coli Escherichia coli MIC > 138.0 ug.mL-1 PMID[510187]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 138.0 ug.mL-1 PMID[510187]
NPT21 Organism Aspergillus niger Aspergillus niger MIC > 138.0 ug.mL-1 PMID[510187]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472912 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9863 High Similarity NPC260979
0.9796 High Similarity NPC18727
0.9796 High Similarity NPC469550
0.9732 High Similarity NPC472910
0.9732 High Similarity NPC472913
0.9732 High Similarity NPC472914
0.9732 High Similarity NPC129684
0.9732 High Similarity NPC222814
0.9732 High Similarity NPC245758
0.9732 High Similarity NPC96167
0.9732 High Similarity NPC472911
0.9732 High Similarity NPC299520
0.9728 High Similarity NPC257648
0.9728 High Similarity NPC477231
0.9728 High Similarity NPC302950
0.9728 High Similarity NPC219582
0.9728 High Similarity NPC236637
0.9724 High Similarity NPC3036
0.9664 High Similarity NPC195796
0.9664 High Similarity NPC291878
0.9664 High Similarity NPC278778
0.9664 High Similarity NPC35038
0.966 High Similarity NPC31363
0.9658 High Similarity NPC105512
0.96 High Similarity NPC472598
0.96 High Similarity NPC291508
0.96 High Similarity NPC474055
0.96 High Similarity NPC156057
0.96 High Similarity NPC48208
0.96 High Similarity NPC471515
0.96 High Similarity NPC469584
0.96 High Similarity NPC475267
0.96 High Similarity NPC67876
0.96 High Similarity NPC27337
0.96 High Similarity NPC162869
0.96 High Similarity NPC471479
0.96 High Similarity NPC474208
0.96 High Similarity NPC474836
0.9597 High Similarity NPC477503
0.9597 High Similarity NPC230149
0.9597 High Similarity NPC168247
0.9597 High Similarity NPC472909
0.9597 High Similarity NPC255807
0.9597 High Similarity NPC117992
0.9597 High Similarity NPC470327
0.9597 High Similarity NPC152951
0.9597 High Similarity NPC45849
0.9597 High Similarity NPC200761
0.9597 High Similarity NPC57674
0.9597 High Similarity NPC31018
0.9592 High Similarity NPC338131
0.9592 High Similarity NPC29231
0.9539 High Similarity NPC266314
0.9533 High Similarity NPC209614
0.9533 High Similarity NPC326037
0.9533 High Similarity NPC470328
0.9533 High Similarity NPC472626
0.9533 High Similarity NPC472916
0.9533 High Similarity NPC13858
0.9533 High Similarity NPC255106
0.9533 High Similarity NPC235165
0.9533 High Similarity NPC320825
0.9533 High Similarity NPC471500
0.953 High Similarity NPC273462
0.953 High Similarity NPC49402
0.953 High Similarity NPC227337
0.953 High Similarity NPC192083
0.953 High Similarity NPC70433
0.953 High Similarity NPC213896
0.953 High Similarity NPC33051
0.9524 High Similarity NPC177298
0.9524 High Similarity NPC223579
0.9524 High Similarity NPC183950
0.9524 High Similarity NPC48479
0.9524 High Similarity NPC137062
0.9524 High Similarity NPC52005
0.9524 High Similarity NPC287101
0.9521 High Similarity NPC95864
0.9477 High Similarity NPC474162
0.9477 High Similarity NPC474150
0.9474 High Similarity NPC472624
0.9474 High Similarity NPC474960
0.9474 High Similarity NPC282009
0.9474 High Similarity NPC36217
0.9474 High Similarity NPC192686
0.9474 High Similarity NPC119209
0.9474 High Similarity NPC287328
0.9474 High Similarity NPC118256
0.947 High Similarity NPC210084
0.947 High Similarity NPC52889
0.947 High Similarity NPC78225
0.947 High Similarity NPC52530
0.947 High Similarity NPC181960
0.947 High Similarity NPC472963
0.947 High Similarity NPC108456
0.947 High Similarity NPC99597
0.947 High Similarity NPC223787
0.9467 High Similarity NPC213622
0.9467 High Similarity NPC37392
0.9467 High Similarity NPC256925
0.9467 High Similarity NPC226025
0.9467 High Similarity NPC67396
0.9467 High Similarity NPC2928
0.9467 High Similarity NPC234255
0.9467 High Similarity NPC321779
0.9463 High Similarity NPC39732
0.9463 High Similarity NPC199100
0.9463 High Similarity NPC180234
0.9463 High Similarity NPC60972
0.9463 High Similarity NPC471982
0.9463 High Similarity NPC120537
0.9463 High Similarity NPC106976
0.9456 High Similarity NPC321011
0.9456 High Similarity NPC120464
0.9456 High Similarity NPC196277
0.9456 High Similarity NPC203747
0.9456 High Similarity NPC188679
0.9456 High Similarity NPC80710
0.9456 High Similarity NPC43669
0.9456 High Similarity NPC294852
0.9456 High Similarity NPC272721
0.9456 High Similarity NPC139364
0.9456 High Similarity NPC195202
0.9456 High Similarity NPC254702
0.9456 High Similarity NPC194653
0.9412 High Similarity NPC474038
0.9412 High Similarity NPC472634
0.9412 High Similarity NPC471499
0.9412 High Similarity NPC472632
0.9412 High Similarity NPC471210
0.9412 High Similarity NPC26326
0.9412 High Similarity NPC158188
0.9408 High Similarity NPC184755
0.9408 High Similarity NPC250214
0.9408 High Similarity NPC74178
0.9408 High Similarity NPC55738
0.9408 High Similarity NPC204879
0.9408 High Similarity NPC152904
0.9408 High Similarity NPC95936
0.9408 High Similarity NPC22192
0.9404 High Similarity NPC474638
0.9404 High Similarity NPC68093
0.9404 High Similarity NPC24640
0.9404 High Similarity NPC472455
0.9404 High Similarity NPC472907
0.9404 High Similarity NPC250922
0.9404 High Similarity NPC191146
0.94 High Similarity NPC292214
0.94 High Similarity NPC167091
0.94 High Similarity NPC298692
0.94 High Similarity NPC255350
0.94 High Similarity NPC472905
0.94 High Similarity NPC271779
0.94 High Similarity NPC472915
0.94 High Similarity NPC160951
0.94 High Similarity NPC231018
0.94 High Similarity NPC274327
0.94 High Similarity NPC270620
0.94 High Similarity NPC183878
0.94 High Similarity NPC88645
0.94 High Similarity NPC47781
0.94 High Similarity NPC176775
0.94 High Similarity NPC69394
0.94 High Similarity NPC74924
0.94 High Similarity NPC145379
0.94 High Similarity NPC78326
0.94 High Similarity NPC236223
0.94 High Similarity NPC179126
0.94 High Similarity NPC141212
0.94 High Similarity NPC206238
0.94 High Similarity NPC22519
0.9396 High Similarity NPC125062
0.9396 High Similarity NPC252933
0.9396 High Similarity NPC54394
0.9396 High Similarity NPC256406
0.9396 High Similarity NPC117579
0.9396 High Similarity NPC200740
0.9392 High Similarity NPC139293
0.9392 High Similarity NPC69430
0.9392 High Similarity NPC183959
0.9392 High Similarity NPC333691
0.9392 High Similarity NPC264550
0.9392 High Similarity NPC1612
0.9392 High Similarity NPC200060
0.9392 High Similarity NPC40290
0.9392 High Similarity NPC142876
0.9392 High Similarity NPC264289
0.9392 High Similarity NPC195763
0.9388 High Similarity NPC62536
0.9388 High Similarity NPC470511
0.9388 High Similarity NPC33265
0.9388 High Similarity NPC77378
0.9388 High Similarity NPC12200
0.9388 High Similarity NPC108406
0.9351 High Similarity NPC472635
0.9351 High Similarity NPC476247
0.9351 High Similarity NPC474034
0.9351 High Similarity NPC474033
0.9351 High Similarity NPC201800
0.9351 High Similarity NPC472964

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472912 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9728 High Similarity NPD1934 Approved
0.953 High Similarity NPD2393 Clinical (unspecified phase)
0.94 High Similarity NPD2801 Approved
0.9276 High Similarity NPD3882 Suspended
0.9231 High Similarity NPD6166 Phase 2
0.9231 High Similarity NPD6167 Clinical (unspecified phase)
0.9231 High Similarity NPD6168 Clinical (unspecified phase)
0.9184 High Similarity NPD1511 Approved
0.906 High Similarity NPD1512 Approved
0.9 High Similarity NPD7074 Phase 3
0.8961 High Similarity NPD3817 Phase 2
0.8938 High Similarity NPD7054 Approved
0.8904 High Similarity NPD1550 Clinical (unspecified phase)
0.8904 High Similarity NPD1552 Clinical (unspecified phase)
0.8882 High Similarity NPD7472 Approved
0.8875 High Similarity NPD3818 Discontinued
0.8844 High Similarity NPD1549 Phase 2
0.8782 High Similarity NPD4868 Clinical (unspecified phase)
0.8742 High Similarity NPD4378 Clinical (unspecified phase)
0.8734 High Similarity NPD5494 Approved
0.8726 High Similarity NPD7075 Discontinued
0.8712 High Similarity NPD6797 Phase 2
0.8701 High Similarity NPD4380 Phase 2
0.8659 High Similarity NPD7251 Discontinued
0.8654 High Similarity NPD7096 Clinical (unspecified phase)
0.8639 High Similarity NPD1510 Phase 2
0.8608 High Similarity NPD4381 Clinical (unspecified phase)
0.8606 High Similarity NPD4338 Clinical (unspecified phase)
0.8606 High Similarity NPD7808 Phase 3
0.8599 High Similarity NPD8443 Clinical (unspecified phase)
0.8581 High Similarity NPD2796 Approved
0.8553 High Similarity NPD6799 Approved
0.8535 High Similarity NPD7819 Suspended
0.8493 Intermediate Similarity NPD1240 Approved
0.8466 Intermediate Similarity NPD7473 Discontinued
0.8408 Intermediate Similarity NPD7411 Suspended
0.8395 Intermediate Similarity NPD6232 Discontinued
0.8378 Intermediate Similarity NPD1607 Approved
0.8377 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8367 Intermediate Similarity NPD943 Approved
0.8354 Intermediate Similarity NPD6801 Discontinued
0.8344 Intermediate Similarity NPD6599 Discontinued
0.8302 Intermediate Similarity NPD1465 Phase 2
0.8263 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8253 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8253 Intermediate Similarity NPD5844 Phase 1
0.8243 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8243 Intermediate Similarity NPD1613 Approved
0.8224 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD6959 Discontinued
0.8219 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8151 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD3926 Phase 2
0.8107 Intermediate Similarity NPD6559 Discontinued
0.8098 Intermediate Similarity NPD919 Approved
0.8072 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8041 Intermediate Similarity NPD3027 Phase 3
0.8038 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8038 Intermediate Similarity NPD5403 Approved
0.8025 Intermediate Similarity NPD5402 Approved
0.8 Intermediate Similarity NPD7199 Phase 2
0.8 Intermediate Similarity NPD1247 Approved
0.8 Intermediate Similarity NPD3750 Approved
0.7987 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD7768 Phase 2
0.7974 Intermediate Similarity NPD1551 Phase 2
0.7974 Intermediate Similarity NPD6100 Approved
0.7974 Intermediate Similarity NPD6099 Approved
0.7947 Intermediate Similarity NPD230 Phase 1
0.7935 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD3749 Approved
0.7911 Intermediate Similarity NPD5401 Approved
0.7904 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD4628 Phase 3
0.7857 Intermediate Similarity NPD2935 Discontinued
0.7852 Intermediate Similarity NPD4908 Phase 1
0.7848 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD447 Suspended
0.7829 Intermediate Similarity NPD1933 Approved
0.7821 Intermediate Similarity NPD2800 Approved
0.7799 Intermediate Similarity NPD2533 Approved
0.7799 Intermediate Similarity NPD2534 Approved
0.7799 Intermediate Similarity NPD2532 Approved
0.779 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD9494 Approved
0.7778 Intermediate Similarity NPD6651 Approved
0.7771 Intermediate Similarity NPD6234 Discontinued
0.7755 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD1610 Phase 2
0.7692 Intermediate Similarity NPD2344 Approved
0.7677 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD3748 Approved
0.7677 Intermediate Similarity NPD2799 Discontinued
0.7658 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD1653 Approved
0.763 Intermediate Similarity NPD5953 Discontinued
0.7619 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD1243 Approved
0.7593 Intermediate Similarity NPD920 Approved
0.7584 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD37 Approved
0.7564 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD7228 Approved
0.7558 Intermediate Similarity NPD3751 Discontinued
0.7545 Intermediate Similarity NPD4965 Approved
0.7545 Intermediate Similarity NPD4966 Approved
0.7545 Intermediate Similarity NPD4967 Phase 2
0.7533 Intermediate Similarity NPD1203 Approved
0.7529 Intermediate Similarity NPD3787 Discontinued
0.7516 Intermediate Similarity NPD3268 Approved
0.7514 Intermediate Similarity NPD7286 Phase 2
0.75 Intermediate Similarity NPD2309 Approved
0.75 Intermediate Similarity NPD3226 Approved
0.75 Intermediate Similarity NPD6190 Approved
0.75 Intermediate Similarity NPD6832 Phase 2
0.7486 Intermediate Similarity NPD7685 Pre-registration
0.7483 Intermediate Similarity NPD2798 Approved
0.7469 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD2346 Discontinued
0.7466 Intermediate Similarity NPD1548 Phase 1
0.7452 Intermediate Similarity NPD7033 Discontinued
0.745 Intermediate Similarity NPD1608 Approved
0.7418 Intermediate Similarity NPD4363 Phase 3
0.7418 Intermediate Similarity NPD4360 Phase 2
0.7417 Intermediate Similarity NPD2797 Approved
0.7407 Intermediate Similarity NPD7390 Discontinued
0.7403 Intermediate Similarity NPD2313 Discontinued
0.7403 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD6798 Discontinued
0.7401 Intermediate Similarity NPD8312 Approved
0.7401 Intermediate Similarity NPD8313 Approved
0.74 Intermediate Similarity NPD4749 Approved
0.7384 Intermediate Similarity NPD5242 Approved
0.7381 Intermediate Similarity NPD5353 Approved
0.7372 Intermediate Similarity NPD6355 Discontinued
0.7372 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD4625 Phase 3
0.7337 Intermediate Similarity NPD5019 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD9717 Approved
0.7326 Intermediate Similarity NPD5710 Approved
0.7326 Intermediate Similarity NPD5711 Approved
0.732 Intermediate Similarity NPD2861 Phase 2
0.732 Intermediate Similarity NPD3018 Phase 2
0.7308 Intermediate Similarity NPD4060 Phase 1
0.7305 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD7458 Discontinued
0.7289 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD4361 Phase 2
0.7283 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD5536 Phase 2
0.7278 Intermediate Similarity NPD8434 Phase 2
0.7267 Intermediate Similarity NPD2654 Approved
0.7267 Intermediate Similarity NPD422 Phase 1
0.7261 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD5124 Phase 1
0.7248 Intermediate Similarity NPD17 Approved
0.7241 Intermediate Similarity NPD2403 Approved
0.7233 Intermediate Similarity NPD4308 Phase 3
0.7225 Intermediate Similarity NPD7229 Phase 3
0.7222 Intermediate Similarity NPD4110 Phase 3
0.7222 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD9269 Phase 2
0.7202 Intermediate Similarity NPD6385 Approved
0.7202 Intermediate Similarity NPD6386 Approved
0.7195 Intermediate Similarity NPD4357 Discontinued
0.719 Intermediate Similarity NPD3267 Approved
0.719 Intermediate Similarity NPD3266 Approved
0.7182 Intermediate Similarity NPD8150 Discontinued
0.7179 Intermediate Similarity NPD411 Approved
0.7173 Intermediate Similarity NPD7584 Approved
0.7171 Intermediate Similarity NPD2982 Phase 2
0.7171 Intermediate Similarity NPD2983 Phase 2
0.716 Intermediate Similarity NPD6844 Discontinued
0.716 Intermediate Similarity NPD1652 Phase 2
0.7152 Intermediate Similarity NPD1201 Approved
0.7152 Intermediate Similarity NPD4661 Approved
0.7152 Intermediate Similarity NPD4662 Approved
0.7151 Intermediate Similarity NPD7549 Discontinued
0.7143 Intermediate Similarity NPD7266 Discontinued
0.7134 Intermediate Similarity NPD6233 Phase 2
0.7128 Intermediate Similarity NPD6778 Approved
0.7128 Intermediate Similarity NPD6779 Approved
0.7128 Intermediate Similarity NPD6780 Approved
0.7128 Intermediate Similarity NPD6776 Approved
0.7128 Intermediate Similarity NPD6782 Approved
0.7128 Intermediate Similarity NPD6777 Approved
0.7128 Intermediate Similarity NPD6781 Approved
0.7124 Intermediate Similarity NPD3225 Approved
0.7123 Intermediate Similarity NPD5283 Phase 1
0.7117 Intermediate Similarity NPD8166 Discontinued
0.7114 Intermediate Similarity NPD9545 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data